NCT05042765

Brief Summary

For the purpose of this anonymous, observational pilot survey, the investigators will define "entheogens" as substances, generally derived from plants, that are ingested in order to impact one's consciousness for therapeutic, religious, or spiritual purposes. This survey will focus on the naturalistic use of entheogens and other substances including kambo, ayahuasca, hapé, bufo, and sananga typically used in specific cultural and spiritual contexts for healing. There are substantial limitations to what the healthcare community knows about the intentions, motivations, experiences, health behaviors, and demographics of people who decide to participate in entheogen therapy centers or retreats and their willingness to participate in future research studies. The primary goal of this observational pilot survey is to collect self-reported, anonymous data from people who have opted to participate in entheogen therapy centers and retreats during the last five (5) years on the topics of their initial intentions, motivations, experiences, demographics, and willingness to participate in future entheogen research. With the support of established therapy and retreat centers, the research team will aim to collect 100 survey responses from unique, unidentified individuals who have participated in some form of entheogen therapy or treatment during the last five (5) years. Those who choose to fill out the survey will be at least 18 years of age, fluent in English, and self-reporting participation in therapy or a retreat which utilized entheogens in a naturalistic setting in the past five (5) years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 13, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

September 16, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2022

Completed
Last Updated

January 27, 2022

Status Verified

January 1, 2022

Enrollment Period

4 months

First QC Date

August 30, 2021

Last Update Submit

January 26, 2022

Conditions

Keywords

EntheogenPsychedelicHallucinogenKamboAyahuascaHapéBufoSananga

Outcome Measures

Primary Outcomes (1)

  • Entheogen Use in Naturalistic Retreat & Therapeutic Settings

    The primary outcome will be self-reported experiences related to entheogen use in naturalistic retreat and therapeutic settings.

    Entheogen use will have occured within the last 5 years

Interventions

self-reported participation in therapy or a retreat in a naturalistic setting that incorporated the use of entheogens in the past five (5) years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People over the age of 18 years old who are fluent in English and have self-reported participation in entheogen therapy centers or retreats in naturalistic settings during the past five (5) years.

You may qualify if:

  • \>18 years old
  • Fluent in English
  • Self-reported participation in therapy or a retreat in a naturalistic setting that incorporated the use of entheogens in the past five (5) years

You may not qualify if:

  • Inability to provide informed consent
  • Inability to complete the online questionnaire
  • No self-reported participation in therapy or a retreat in a naturalistic setting that incorporated the use of entheogens in the past five (5) years
  • Self-reported participation in therapy or a retreat in naturalistic setting that incorporated the use of entheogens greater than five (5) years ago

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vireo Health of New York

Queens, New York, 11373, United States

Location

Study Officials

  • Stephen Dahmer, ND

    Resurgent Biosciences, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 30, 2021

First Posted

September 13, 2021

Study Start

September 16, 2021

Primary Completion

January 12, 2022

Study Completion

January 12, 2022

Last Updated

January 27, 2022

Record last verified: 2022-01

Locations